Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology in irritable bowel syndrome.

M Camilleri1

  • 1Enteric Neuroscience Program, Gastroenterology Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.

Drug News & Perspectives
|June 19, 2003
PubMed
Summary

Irritable bowel syndrome (IBS) is a distressing condition impacting quality of life and healthcare costs. Research explores its complex mechanisms, including gut motility, sensory function, and neurobiology, to develop new treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-center Clinical Experience of Diarrhea in Patients Treated With Sorafenib Shows Rare Development of Pancreatic Atrophy.

Gastro hep advances·2024
Same author

Rectal Evacuation Disorders in Patients Presenting With Chronic Functional Diarrhea.

Gastro hep advances·2024
Same author

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome.

Gastro hep advances·2023
Same author

Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans.

Neurogastroenterology and motility·2018
Same author

Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms.

Neurogastroenterology and motility·2018
Same author

Comparison of pH and motility of the small intestine of healthy subjects and patients with symptomatic constipation using the wireless motility capsule.

International journal of pharmaceutics·2018

Area of Science:

  • Gastroenterology and Neurogastroenterology

Background:

  • Irritable bowel syndrome (IBS) significantly impairs patient quality of life and incurs substantial healthcare costs.
  • IBS pathogenesis involves a complex interplay of altered gastrointestinal motility, heightened intestinal sensitivity, and psychosocial factors.

Purpose of the Study:

  • This article reviews the pathophysiological mechanisms underlying IBS development.
  • Focus is placed on the potential roles of mucosal changes and neurobiology in IBS.

Main Methods:

  • Review of current literature on IBS pathophysiology.
  • Examination of emerging research on neural mediators and pharmacological targets.

Main Results:

  • Altered gut motility, visceral hypersensitivity, and psychosocial factors are key IBS mechanisms.

Related Experiment Videos

  • Mucosal alterations and neurobiological changes are increasingly implicated in IBS pathogenesis.
  • Novel pharmacological agents targeting neural pathways show promise for IBS treatment.

    • Conclusions:

    • Understanding the intricate pathophysiological mechanisms of IBS is crucial for effective treatment.
    • Emerging therapies targeting neural mediators offer potential for improved clinical management of IBS.
    • Further research and clinical trials are needed to clarify the role of new pharmacological agents in IBS treatment.